Ifsofamide and Periostitis - a phase IV clinical study of FDA data
Summary:
We study 608 people who take Ifsofamide (ifosfamide) or have Periostitis. No report of Periostitis is found in people who take Ifsofamide.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Ifsofamide?
Ifsofamide has active ingredients of ifosfamide. eHealthMe is studying from 5 Ifsofamide users. Check the latest studies of Ifsofamide.
What is Periostitis?
Periostitis (inflammation of the periosteum, a layer of connective tissue that surrounds bone) is found to be associated with 102 drugs and 155 conditions by eHealthMe. Check the latest studies of Periostitis.
No report is found.
Do you take Ifsofamide and have Periostitis?
- Check whether Periostitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Ifsofamide:
- Ifsofamide (5 reports)
Periostitis treatments and more:
- Periostitis (603 reports)
How severe was Periostitis and when was it recovered:
Expand to all the drugs that have ingredients of ifosfamide:
Browse all side effects of Ifsofamide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Periostitis:
Browse all the conditions that are associated with Periostitis:
How the study uses the data?
The study uses data from the FDA. It is based on ifosfamide (the active ingredients of Ifsofamide) and Ifsofamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lescol Xl vs. Garlic, side effect and effectiveness comparison - a second ago
- Zetia and Restlessness for Women aged 60+ - 2 seconds ago
- Zetia and Agitation for Women aged 60+ - 2 seconds ago
- Depression and Dizziness - 4 seconds ago
- Nasonex and Renal Failure Chronic Aggravated for Men aged 60+ - 9 seconds ago
- Oxazepam vs. Topamax, side effect and effectiveness comparison - 18 seconds ago
- Could Hydroxyurea cause Bleeding Disorders? - 20 seconds ago
- Januvia and Nasal Decongestion Therapy for Women aged 40-49 - 20 seconds ago
- Januvia and Stuffy Nose for Women aged 40-49 - 20 seconds ago
- Januvia and Nose - Congested for Women aged 40-49 - 21 seconds ago